Vasomedical, Inc. announced that it has received US FDA 510 (k) clearance to market its Vasomedical-BIOX 1305 ECG Holter Monitor and CB Series Ambulatory ECG Analysis Software. Vasomedical-BIOX 1305 Holter Monitor which already received CE Marking certification to market in the EU countries, is a compact, lightweight, 3-channel ECG Holter monitor designed for monitoring a patient's cardiac rhythm for 24 to 72 hours and recording ECG on a standard SD memory card. The 1305 monitor features a high signal sampling rate and high resolution digital recording for comprehensive data analysis. The data recorded on the 1305 monitor is utilized in the early detection of cardiac abnormalities such as ischemia and arrhythmia. The proprietary Vasomedical-BIOX CB Series Analysis Software quickly analyzes data recorded by the Model 1305. The CB series software provides clear, quick, and accurate recognition of QRS complexes and classification; a proprietary two-tier automatic classification process for "suspicious" waveforms; comprehensive event reports and ST-segment reports; and many other data viewing, analysis, and reporting capabilities.